Literature DB >> 7890404

Involvement of Ras-related Rho proteins in the mechanisms of action of Clostridium difficile toxin A and toxin B.

S T Dillon1, E J Rubin, M Yakubovich, C Pothoulakis, J T LaMont, L A Feig, R J Gilbert.   

Abstract

Toxins A and B of Clostridium difficile are responsible for pseudomembranous colitis, a disease that afflicts a substantial number of hospitalized patients treated with antibiotics. A major effect of these proteins is the disruption of the actin cytoskeleton. Recently, I. Just, G. Fritz, K. Aktories, M. Giry, M. R. Popoff, P. Boquet, S. Hegenbarth, and C. von Eichel-Streiber (J. Biol. Chem. 269:10706-10712, 1994) implicated Rho proteins as cellular targets of C. difficile toxin B, since pretreatment of cells or purified Rho with toxin prevented subsequent ADP-ribosylation of Rho by exoenzyme C3. Moreover, they showed that overexpression of Rho proteins in cells suppressed cell rounding normally associated with exposure of cells to C. difficile toxin B. Here we expand these findings by showing directly that Rho proteins are covalently modified by both C. difficile toxins A and B. In addition, we demonstrate that the stability of toxin-modified Rho in NIH 3T3 cells is dramatically reduced. Finally, we show that C. difficile toxins A and B do not have similar effects on the closely related Rac and CDC42 GTP-binding proteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890404      PMCID: PMC173169          DOI: 10.1128/iai.63.4.1421-1426.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors.

Authors:  A J Ridley; A Hall
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  A C-terminal signal prevents secretion of luminal ER proteins.

Authors:  S Munro; H R Pelham
Journal:  Cell       Date:  1987-03-13       Impact factor: 41.582

4.  Biochemical studies on the effect of Clostridium difficile toxin B on actin in vivo and in vitro.

Authors:  M J Mitchell; B E Laughon; S Lin
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

5.  Purification and properties of Clostridium difficile cytotoxin B.

Authors:  C Pothoulakis; L M Barone; R Ely; B Faris; M E Clark; C Franzblau; J T LaMont
Journal:  J Biol Chem       Date:  1986-01-25       Impact factor: 5.157

6.  Functional modification of a 21-kilodalton G protein when ADP-ribosylated by exoenzyme C3 of Clostridium botulinum.

Authors:  E J Rubin; D M Gill; P Boquet; M R Popoff
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

7.  Ultrastructural effects of Clostridium difficile toxin B on smooth muscle cells and fibroblasts.

Authors:  N Wedel; P Toselli; C Pothoulakis; B Faris; P Oliver; C Franzblau; T LaMont
Journal:  Exp Cell Res       Date:  1983-10-15       Impact factor: 3.905

8.  Differential effects of Clostridium difficile toxins A and B on rabbit ileum.

Authors:  G Triadafilopoulos; C Pothoulakis; M J O'Brien; J T LaMont
Journal:  Gastroenterology       Date:  1987-08       Impact factor: 22.682

9.  Comparison of two toxins produced by Clostridium difficile.

Authors:  N S Taylor; G M Thorne; J G Bartlett
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

10.  Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.

Authors:  G I Evan; G K Lewis; G Ramsay; J M Bishop
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

View more
  25 in total

Review 1.  Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation.

Authors:  J Berkes; V K Viswanathan; S D Savkovic; G Hecht
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

2.  Toxin production by Campylobacter spp.

Authors:  T M Wassenaar
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

3.  Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin A.

Authors:  C Pothoulakis; R J Gilbert; C Cladaras; I Castagliuolo; G Semenza; Y Hitti; J S Montcrief; J Linevsky; C P Kelly; S Nikulasson; H P Desai; T D Wilkins; J T LaMont
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

4.  Rho proteins play a critical role in cell migration during the early phase of mucosal restitution.

Authors:  M F Santos; S A McCormack; Z Guo; J Okolicany; Y Zheng; L R Johnson; G Tigyi
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

5.  Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor.

Authors:  N Mani; B Dupuy
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

6.  Activation of Rho GTPases by Escherichia coli cytotoxic necrotizing factor 1 increases intestinal permeability in Caco-2 cells.

Authors:  R Gerhard; G Schmidt; F Hofmann; K Aktories
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

7.  Clostridium difficile infection of the gut.

Authors:  A P Dodson; S P Borriello
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

Review 8.  Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.

Authors:  C L Sears; J B Kaper
Journal:  Microbiol Rev       Date:  1996-03

9.  Positive regulation of Clostridium difficile toxins.

Authors:  J S Moncrief; L A Barroso; T D Wilkins
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

10.  Nonantimicrobial drug targets for Clostridium difficile infections.

Authors:  Charles Darkoh; Magdalena Deaton; Herbert L DuPont
Journal:  Future Microbiol       Date:  2017-07-31       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.